Phase
Condition
Gastrointestinal Diseases And Disorders
Ulcers
Treatment
N/AClinical Study ID
Ages 12-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Provision of signed informed consent form to participate in the study obtained fromthe adolescent's parent(s)/ legal representative and a signed assent form from theadolescent according to local law
- Male or female subjects between 12 to 17 years of age (inclusive)
- Body weight more than 40 kg
- Female of childbearing potential must have a negative pregnancy test
- If female, and of child-bearing potential, subject must use an acceptable form ofbirth control (hormonal birth control, intrauterine device (IUD), double-barriermethod, or depot contraceptive)
- Routinely accepted indication for undergoing colonoscopy, including but not limited topolyposis coli diagnosis or surveillance, gastrointestinal bleeding, unexplaineddiarrhoea or constipation, surveillance of inflammatory bowel disease or confirmationof mucosal healing, abdominal pain, abnormal endosonography or manometry, anaemia ofunknown aetiology, cancer surveillance
- In the investigator's judgment, the parent(s)/legal representative are/is mentallycompetent to provide informed consent for the subject to participate in the study
- In the investigator's judgement, subject is able and willing to follow studyprocedures including drug administration and response to questionnaires
Exclusion
Exclusion Criteria:
- Subject with known or suspected ileus, gastrointestinal obstruction, gastric retention (gastroparesis), rectal impaction, toxic colitis, severe ulcerative colitis or toxicmegacolon, advanced carcinoma, swallowing disorders
- Subject with known or suspected inflammatory bowel disease (Crohn's disease,ulcerative colitis) in moderate to severe active phase defined by Paediatric Crohn'sDisease Activity Index (PCDAI) >30 or Paediatric Ulcerative Colitis Index (PUCAI) >34
- Subject with bowel perforation or increased risk of bowel perforation, includingconnective tissue disorders or recent bowel surgery
- Subject with previous significant gastrointestinal surgery (e.g. colostomy, colectomy,gastric bypass, stomach stapling)
- Subject with uncontrolled pre-existing electrolyte abnormalities, or with electrolyteabnormalities based on Visit 1 laboratory results such as hypernatremia, hyponatremia,hyperphosphatemia, hypokalaemia, hypocalcaemia, uncorrected dehydration, or secondaryto the use of medications such as diuretics or angiotensin converting enzymeinhibitors judged clinically significant by the investigator
- Subject with a prior history or current condition of severe renal (estimatedglomerular filtration rate (GFR) less than 30 mL/min/1.73 m^2 as calculated by usingthe Schwartz bedside equation* [Schwartz et al, 2009]**), liver (ascites, Child-PughC), cardiac insufficiency (including congestive heart failure all grades) orhyperuricemia *The estimated GFR will be calculated in patients with elevated creatinine at baseline **Schwartz GJ and Work DF. Measurement and Estimation of GFR in Children andAdolescents. Clin J Am Soc Nephrol. 2009; 4: 1832-1843
- Female subject who is pregnant or lactating
- Subject who has participated in another investigational drug treatment within the last 90 days before the first study visit
- Subject with phenylketonuria
- Subject with history of asthma or hypersensitivity to any ingredient of either drugproduct
- Subject for whom intake of substances likely to affect gastrointestinal motility orurinary flow rate is required
- Subject with requirement to take any other oral medication within 3 hours of startingthe bowel preparation, as this may impact medication absorption
- Subject with tendency for nausea and/or vomiting
- Subject with impaired consciousness that predisposes them to pulmonary aspiration orwho have known swallowing disorders
- Subject with history of major medical/psychiatric conditions that, in the judgment ofthe investigator, would compromise safety in the study
- Subject with mental or psychiatric condition rendering the subject unable tounderstand the nature, scope and possible consequences of the study, and/or evidenceof an uncooperative attitude
- Subject with a condition that, in the opinion of the investigator, might increase therisk to the subject or decrease the chance of obtaining satisfactory data needed toachieve the objectives of the study
- Subject who has previous enrolment in this study or concomitant enrolment in otherclinical studies
Study Design
Connect with a study center
Fakultní nemocnice Královské Vinohrady
Praha, 100 34
CzechiaSite Not Available
Všeobecná fakultní nemocnice v Praze
Praha, 128 08
CzechiaSite Not Available
Université de Picardie Jules Verne
Amiens, 80054
FranceSite Not Available
Hôpital Femme Mère-Enfant
Bron, 69677
FranceSite Not Available
CHU de Lille - Hôpital Jeanne de Flandre
Lille, 59037
FranceSite Not Available
Hôpital Necker Enfants Malades
Paris, 75015
FranceSite Not Available
Uniklinikum Essen
Essen, 45147
GermanySite Not Available
Evang Krankenhaus Hamm
Hamm, 59063
GermanySite Not Available
Universitätsklinikum Leipzig, Klinik und Poliklinik für Kinder- und Jugendmedizin
Leipzig, 04103
GermanySite Not Available
Klinikum Ulm
Ulm, 89075
GermanySite Not Available
HELIOS Klinikum Wuppertal
Wuppertal, 42283
GermanySite Not Available
ORN Santobono-Pausilipon Padiglione Santobono
Napoli, 680 122
ItalySite Not Available
Ospedale "Spirito Santo" U.D.C.
Pescara, 65125
ItalySite Not Available
Azienda Ospedaliero-Universitaria Sant'Andrea
Roma, 00189
ItalySite Not Available
Noord West Ziekenhuisgroep
Alkmaar, 1814 HB
NetherlandsSite Not Available
AMC Emma kinderziekenhuis
Amsterdam, 1105 AZ
NetherlandsSite Not Available
Maasstad ziekenhuis
Rotterdam, 3079 DZ
NetherlandsSite Not Available
Maxima Medisch Centrum
Veldhoven, 5504 DB
NetherlandsSite Not Available
Copernicus Podmiot Leczniczy Sp. z.o.o
Gdańsk, 80-803
PolandSite Not Available
Samodzielny Publiczny Szpital Kliniczny Nr 6 Śląskiego
Katowice, 40-752
PolandSite Not Available
Uniwersytecki Szpital Dziecięcy w Krakowie
Kraków, 30-663
PolandSite Not Available
Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku
Lublin, 20-093
PolandSite Not Available
Uniwersytecki Szpital Dziecięcy w Lublinie
Lublin, 20-093
PolandSite Not Available
Instytut "Pomnik - Centrum Zdrowia Dziecka"
Warszawa, 04-730
PolandSite Not Available
Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wrocławiu
Wrocław, 50-369
PolandSite Not Available
Samodzielny Publiczny Szpital Kliniczny Nr 1
Zabrze, 41-800
PolandSite Not Available
Instytut Centrum Zdrowia Matki Polki
Łódź, 93-338
PolandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.